J 2024

STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma

PRUTSCH, Nicole; Shuning HE; Alla BEREZOVSKAYA; Adam D DURBIN; Neekesh V DHARIA et. al.

Basic information

Original name

STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma

Authors

PRUTSCH, Nicole; Shuning HE; Alla BEREZOVSKAYA; Adam D DURBIN; Neekesh V DHARIA; Kelsey A MAHER; Jamie D MATTHEWS; Lucy HARE; Suzanne Dawn TURNER; Kimberly STEGMAIER; Lukas KENNER; Olaf MERKEL; A Thomas LOOK; Brian J ABRAHAM and Mark W ZIMMERMAN

Edition

CELL REPORTS MEDICINE, AMSTERDAM, ELSEVIER, 2024, 2666-3791

Other information

Language

English

Type of outcome

Article in a journal

Country of publisher

Netherlands

Confidentiality degree

is not subject to a state or trade secret

References:

Organization

Lékařská fakulta – Repository – Repository

UT WoS

001222093700001

EID Scopus

2-s2.0-85188151080

Keywords in English

anaplastic large cell lymphoma; STAT3

Links

LX22NPO5102, research and development project.
Changed: 12/6/2024 04:49, RNDr. Daniel Jakubík

Abstract

V originále

Anaplastic large cell lymphoma (ALCL) is an aggressive, CD30 + T cell lymphoma of children and adults. ALK fusion transcripts or mutations in the JAK-STAT pathway are observed in most ALCL tumors, but the mechanisms underlying tumorigenesis are not fully understood. Here, we show that dysregulated STAT3 in ALCL cooccupies enhancers with master transcription factors BATF3, IRF4, and IKZF1 to form a core regulatory circuit that establishes and maintains the malignant cell state in ALCL. Critical downstream targets of this network in ALCL cells include the protooncogene MYC , which requires active STAT3 to facilitate high levels of MYC transcription. The core autoregulatory transcriptional circuitry activity is reinforced by MYC binding to the enhancer regions associated with STAT3 and each of the core regulatory transcription factors. Thus, activation of STAT3 provides the crucial link between aberrant tyrosine kinase signaling and the core transcriptional machinery that drives tumorigenesis and creates therapeutic vulnerabilities in ALCL.

Files attached